nodes	percent_of_prediction	percent_of_DWPC	metapath
Tasosartan—AGTR2—asthma	0.449	0.743	CbGaD
Tasosartan—AGTR1—asthma	0.155	0.257	CbGaD
Tasosartan—CYP3A4—Fluticasone furoate—asthma	0.0208	0.0796	CbGbCtD
Tasosartan—CYP3A4—Budesonide—asthma	0.0185	0.0709	CbGbCtD
Tasosartan—CYP3A4—Ciclesonide—asthma	0.0169	0.0649	CbGbCtD
Tasosartan—CYP3A4—Indacaterol—asthma	0.0169	0.0649	CbGbCtD
Tasosartan—CYP3A4—Salbutamol—asthma	0.0157	0.0603	CbGbCtD
Tasosartan—CYP3A4—Flunisolide—asthma	0.0157	0.0603	CbGbCtD
Tasosartan—CYP3A4—Salmeterol—asthma	0.0157	0.0603	CbGbCtD
Tasosartan—CYP3A4—Zileuton—asthma	0.014	0.0538	CbGbCtD
Tasosartan—CYP3A4—Ipratropium bromide—asthma	0.014	0.0538	CbGbCtD
Tasosartan—CYP3A4—Fluticasone Propionate—asthma	0.0134	0.0513	CbGbCtD
Tasosartan—CYP3A4—Zafirlukast—asthma	0.0123	0.0473	CbGbCtD
Tasosartan—CYP3A4—Tiotropium—asthma	0.0106	0.0407	CbGbCtD
Tasosartan—CYP3A4—Aminophylline—asthma	0.0101	0.0389	CbGbCtD
Tasosartan—CYP3A4—Theophylline—asthma	0.00953	0.0365	CbGbCtD
Tasosartan—CYP3A4—Montelukast—asthma	0.00904	0.0346	CbGbCtD
Tasosartan—CYP3A4—Loratadine—asthma	0.00904	0.0346	CbGbCtD
Tasosartan—CYP3A4—Methylprednisolone—asthma	0.00826	0.0317	CbGbCtD
Tasosartan—AGTR2—respiratory system—asthma	0.00678	0.29	CbGeAlD
Tasosartan—CYP3A4—Triamcinolone—asthma	0.00626	0.024	CbGbCtD
Tasosartan—CYP3A4—Betamethasone—asthma	0.00537	0.0206	CbGbCtD
Tasosartan—CYP3A4—Prednisolone—asthma	0.0053	0.0203	CbGbCtD
Tasosartan—AGTR2—cardiovascular system—asthma	0.00519	0.222	CbGeAlD
Tasosartan—CYP3A4—Hydrocortisone—asthma	0.00503	0.0193	CbGbCtD
Tasosartan—CYP3A4—Prednisone—asthma	0.00501	0.0192	CbGbCtD
Tasosartan—AGTR2—lung—asthma	0.0036	0.154	CbGeAlD
Tasosartan—CYP3A4—Dexamethasone—asthma	0.00313	0.012	CbGbCtD
Tasosartan—AGTR1—adrenal cortex—asthma	0.00127	0.0546	CbGeAlD
Tasosartan—AGTR1—epithelium—asthma	0.00127	0.0543	CbGeAlD
Tasosartan—AGTR1—smooth muscle tissue—asthma	0.00122	0.0524	CbGeAlD
Tasosartan—AGTR1—cardiovascular system—asthma	0.00116	0.0498	CbGeAlD
Tasosartan—AGTR1—trachea—asthma	0.00112	0.048	CbGeAlD
Tasosartan—Azilsartan medoxomil—AGTR1—asthma	0.00101	0.239	CrCbGaD
Tasosartan—Forasartan—AGTR1—asthma	0.00094	0.222	CrCbGaD
Tasosartan—AGTR1—adrenal gland—asthma	0.00092	0.0394	CbGeAlD
Tasosartan—AGTR1—lung—asthma	0.000806	0.0345	CbGeAlD
Tasosartan—Valsartan—AGTR1—asthma	0.000494	0.117	CrCbGaD
Tasosartan—Olmesartan—AGTR1—asthma	0.000481	0.114	CrCbGaD
Tasosartan—Irbesartan—AGTR1—asthma	0.000374	0.0885	CrCbGaD
Tasosartan—Candesartan—AGTR1—asthma	0.000374	0.0885	CrCbGaD
Tasosartan—Losartan—AGTR1—asthma	0.000241	0.057	CrCbGaD
Tasosartan—Losartan—ACE—asthma	0.000139	0.033	CrCbGaD
Tasosartan—Valsartan—ALB—asthma	0.000117	0.0276	CrCbGaD
Tasosartan—Losartan—ALB—asthma	5.71e-05	0.0135	CrCbGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL10—asthma	4.09e-05	0.000381	CbGpPWpGaD
Tasosartan—CYP3A4—Tryptophan metabolism—CAT—asthma	4.09e-05	0.00038	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—C3—asthma	4.07e-05	0.000379	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PDE4A—asthma	4.03e-05	0.000375	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—VIP—asthma	4.01e-05	0.000373	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—UTS2—asthma	4.01e-05	0.000373	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—C5AR1—asthma	4.01e-05	0.000373	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—ADRB2—asthma	3.97e-05	0.000369	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—KNG1—asthma	3.92e-05	0.000364	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—POMC—asthma	3.9e-05	0.000363	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—AGTR1—asthma	3.89e-05	0.000362	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR4—asthma	3.85e-05	0.000358	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CCL2—asthma	3.82e-05	0.000355	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6R—asthma	3.81e-05	0.000354	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL10—asthma	3.81e-05	0.000354	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—RHOA—asthma	3.79e-05	0.000352	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CYSLTR1—asthma	3.77e-05	0.000351	CbGpPWpGaD
Tasosartan—AGTR1—Peptide ligand-binding receptors—CXCL8—asthma	3.75e-05	0.000349	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NTRK1—asthma	3.73e-05	0.000347	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2RB—asthma	3.7e-05	0.000345	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ADRB2—asthma	3.69e-05	0.000344	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PDE4D—asthma	3.67e-05	0.000341	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—C5AR1—asthma	3.64e-05	0.000339	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—VIP—asthma	3.64e-05	0.000339	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL11—asthma	3.64e-05	0.000339	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—UTS2—asthma	3.64e-05	0.000339	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FCER2—asthma	3.59e-05	0.000334	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—C3AR1—asthma	3.59e-05	0.000334	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—C5—asthma	3.58e-05	0.000333	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—TACR1—asthma	3.58e-05	0.000333	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—PDE4B—asthma	3.58e-05	0.000333	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—EDN1—asthma	3.55e-05	0.00033	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL5—asthma	3.52e-05	0.000328	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—ITPR1—asthma	3.49e-05	0.000325	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR4—asthma	3.49e-05	0.000325	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CYSLTR2—asthma	3.46e-05	0.000322	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—RHOA—asthma	3.44e-05	0.00032	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2RB—asthma	3.36e-05	0.000313	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTGDR—asthma	3.34e-05	0.000311	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL22—asthma	3.34e-05	0.000311	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LTB4R—asthma	3.34e-05	0.000311	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PDE4D—asthma	3.33e-05	0.00031	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CD86—asthma	3.33e-05	0.00031	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—CXCL8—asthma	3.33e-05	0.000309	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EDN1—asthma	3.3e-05	0.000307	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL5—asthma	3.28e-05	0.000305	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR3—asthma	3.27e-05	0.000304	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PLA2G4A—asthma	3.26e-05	0.000304	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	3.26e-05	0.000303	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PDE4B—asthma	3.25e-05	0.000302	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—C5—asthma	3.25e-05	0.000302	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—TACR1—asthma	3.25e-05	0.000302	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CSF2—asthma	3.23e-05	0.0003	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—NPY—asthma	3.19e-05	0.000297	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	3.18e-05	0.000296	CbGpPWpGaD
Tasosartan—AGTR2—GPCR downstream signaling—IL2—asthma	3.18e-05	0.000296	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCR5—asthma	3.17e-05	0.000295	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SMAD3—asthma	3.14e-05	0.000292	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—C3—asthma	3.1e-05	0.000288	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—AGTR2—asthma	3.08e-05	0.000286	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—CXCL8—asthma	3.02e-05	0.000281	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PPP2CA—asthma	3.01e-05	0.00028	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR3—asthma	2.97e-05	0.000276	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCR5—asthma	2.95e-05	0.000275	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—EDNRB—asthma	2.95e-05	0.000274	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—NPS—asthma	2.92e-05	0.000271	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—TAC1—asthma	2.92e-05	0.000271	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2RA—asthma	2.91e-05	0.000271	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NPY—asthma	2.89e-05	0.000269	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL2—asthma	2.89e-05	0.000269	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—C3—asthma	2.88e-05	0.000268	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCR3—asthma	2.86e-05	0.000266	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—HRH4—asthma	2.84e-05	0.000264	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTGDR2—asthma	2.84e-05	0.000264	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PMCH—asthma	2.84e-05	0.000264	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NPSR1—asthma	2.84e-05	0.000264	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PDGFB—asthma	2.81e-05	0.000261	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—AGTR2—asthma	2.79e-05	0.00026	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CSF2RB—asthma	2.78e-05	0.000259	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TACR2—asthma	2.72e-05	0.000253	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR8—asthma	2.72e-05	0.000253	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL5—asthma	2.71e-05	0.000252	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—LEP—asthma	2.68e-05	0.00025	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EDNRB—asthma	2.67e-05	0.000249	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL17—asthma	2.67e-05	0.000248	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—TAC1—asthma	2.65e-05	0.000246	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—NPS—asthma	2.65e-05	0.000246	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—BDKRB2—asthma	2.62e-05	0.000243	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCR3—asthma	2.6e-05	0.000242	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—FN1—asthma	2.53e-05	0.000236	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADCY2—asthma	2.53e-05	0.000235	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL3—asthma	2.52e-05	0.000235	CbGpPWpGaD
Tasosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	2.52e-05	0.000234	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—asthma	2.49e-05	0.000231	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—POMC—asthma	2.48e-05	0.000231	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL5—asthma	2.46e-05	0.000229	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CCL2—asthma	2.43e-05	0.000226	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KIF3A—asthma	2.38e-05	0.000221	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDE4A—asthma	2.38e-05	0.000221	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—KNG1—asthma	2.38e-05	0.000221	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—BDKRB2—asthma	2.37e-05	0.000221	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL10—asthma	2.31e-05	0.000215	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—POMC—asthma	2.31e-05	0.000215	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADCY2—asthma	2.3e-05	0.000214	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL3—asthma	2.29e-05	0.000213	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CCL2—asthma	2.26e-05	0.00021	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6R—asthma	2.25e-05	0.000209	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ADRB2—asthma	2.24e-05	0.000209	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CYSLTR1—asthma	2.23e-05	0.000207	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—ALDH2—asthma	2.22e-05	0.000206	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—EGFR—asthma	2.21e-05	0.000205	CbGpPWpGaD
Tasosartan—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—asthma	2.21e-05	0.000205	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—KNG1—asthma	2.16e-05	0.000201	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VIP—asthma	2.15e-05	0.0002	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CMA1—asthma	2.15e-05	0.0002	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—C5AR1—asthma	2.15e-05	0.0002	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL11—asthma	2.15e-05	0.0002	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—UTS2—asthma	2.15e-05	0.0002	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—ITPR1—asthma	2.12e-05	0.000197	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTT1—asthma	2.11e-05	0.000196	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—SERPINE1—asthma	2.11e-05	0.000196	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL10—asthma	2.1e-05	0.000195	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR4—asthma	2.06e-05	0.000192	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ADRB2—asthma	2.04e-05	0.00019	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—RHOA—asthma	2.03e-05	0.000189	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT6—asthma	2.02e-05	0.000188	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—NOS3—asthma	2.01e-05	0.000187	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—EDN1—asthma	2.01e-05	0.000187	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCL5—asthma	1.99e-05	0.000185	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2RB—asthma	1.99e-05	0.000185	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDE4D—asthma	1.97e-05	0.000183	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CSF2—asthma	1.96e-05	0.000182	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—ITPR1—asthma	1.93e-05	0.000179	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—C5—asthma	1.92e-05	0.000179	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDE4B—asthma	1.92e-05	0.000179	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TACR1—asthma	1.92e-05	0.000179	CbGpPWpGaD
Tasosartan—AGTR1—GPCR ligand binding—CXCL8—asthma	1.92e-05	0.000178	CbGpPWpGaD
Tasosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—asthma	1.91e-05	0.000178	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EDN1—asthma	1.82e-05	0.000169	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL5—asthma	1.81e-05	0.000168	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PLA2G4A—asthma	1.8e-05	0.000167	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CCR5—asthma	1.79e-05	0.000167	CbGpPWpGaD
Tasosartan—CYP3A4—Phase 1 - Functionalization of compounds—POMC—asthma	1.79e-05	0.000166	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—CXCL8—asthma	1.78e-05	0.000166	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CSF2—asthma	1.78e-05	0.000166	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2RA—asthma	1.77e-05	0.000164	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR3—asthma	1.75e-05	0.000163	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—C3—asthma	1.75e-05	0.000163	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NPY—asthma	1.71e-05	0.000159	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL2—asthma	1.7e-05	0.000159	CbGpPWpGaD
Tasosartan—AGTR2—Signaling by GPCR—IL6—asthma	1.7e-05	0.000158	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—PPP2CA—asthma	1.66e-05	0.000154	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—AGTR2—asthma	1.65e-05	0.000154	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCR5—asthma	1.63e-05	0.000151	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—MMP9—asthma	1.61e-05	0.00015	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—PTEN—asthma	1.6e-05	0.000149	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2RA—asthma	1.6e-05	0.000149	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—C3—asthma	1.59e-05	0.000148	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EDNRB—asthma	1.58e-05	0.000147	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TAC1—asthma	1.56e-05	0.000146	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NPS—asthma	1.56e-05	0.000146	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCR3—asthma	1.53e-05	0.000143	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CYBA—asthma	1.49e-05	0.000138	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTP1—asthma	1.46e-05	0.000136	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL5—asthma	1.45e-05	0.000135	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PARP1—asthma	1.45e-05	0.000135	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—VEGFA—asthma	1.45e-05	0.000135	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTP1—asthma	1.44e-05	0.000134	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—STAT3—asthma	1.43e-05	0.000133	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—BDKRB2—asthma	1.4e-05	0.000131	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—POMC—asthma	1.4e-05	0.00013	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADCY2—asthma	1.36e-05	0.000126	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL3—asthma	1.35e-05	0.000126	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—GSTM1—asthma	1.34e-05	0.000125	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—TGFB1—asthma	1.33e-05	0.000124	CbGpPWpGaD
Tasosartan—CYP3A4—Metapathway biotransformation—GSTM1—asthma	1.33e-05	0.000123	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—EGFR—asthma	1.3e-05	0.000121	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—KNG1—asthma	1.28e-05	0.000119	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—POMC—asthma	1.27e-05	0.000118	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CCL2—asthma	1.24e-05	0.000116	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6R—asthma	1.24e-05	0.000115	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL10—asthma	1.24e-05	0.000115	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—RHOA—asthma	1.23e-05	0.000115	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NTRK1—asthma	1.22e-05	0.000113	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ADRB2—asthma	1.2e-05	0.000112	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—ITPR1—asthma	1.14e-05	0.000106	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—RHOA—asthma	1.12e-05	0.000104	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CD86—asthma	1.08e-05	0.000101	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—CXCL8—asthma	1.08e-05	0.000101	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EDN1—asthma	1.08e-05	0.0001	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL5—asthma	1.07e-05	9.93e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PLA2G4A—asthma	1.06e-05	9.89e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CSF2—asthma	1.05e-05	9.78e-05	CbGpPWpGaD
Tasosartan—AGTR1—GPCR downstream signaling—IL2—asthma	1.04e-05	9.64e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SMAD3—asthma	1.02e-05	9.52e-05	CbGpPWpGaD
Tasosartan—AGTR2—Signaling Pathways—IL6—asthma	1e-05	9.32e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—CXCL8—asthma	9.84e-06	9.16e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PPP2CA—asthma	9.79e-06	9.11e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCR5—asthma	9.62e-06	8.95e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Biological oxidations—POMC—asthma	9.5e-06	8.84e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2RA—asthma	9.48e-06	8.82e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL2—asthma	9.4e-06	8.75e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—C3—asthma	9.4e-06	8.74e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PDGFB—asthma	9.15e-06	8.51e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LTC4S—asthma	8.96e-06	8.34e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—LEP—asthma	8.75e-06	8.14e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—FN1—asthma	8.25e-06	7.68e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—LTA4H—asthma	7.77e-06	7.23e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—POMC—asthma	7.51e-06	6.99e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CCL2—asthma	7.35e-06	6.84e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6R—asthma	7.33e-06	6.82e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—EGFR—asthma	7.19e-06	6.69e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—SERPINE1—asthma	6.86e-06	6.39e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ARG1—asthma	6.79e-06	6.32e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—RHOA—asthma	6.62e-06	6.16e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—NOS3—asthma	6.55e-06	6.1e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDH7A1—asthma	6.14e-06	5.71e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ARG2—asthma	5.89e-06	5.48e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—CXCL8—asthma	5.81e-06	5.41e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL2—asthma	5.56e-06	5.17e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling by GPCR—IL6—asthma	5.53e-06	5.14e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—MMP9—asthma	5.26e-06	4.89e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—PTEN—asthma	5.23e-06	4.86e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALOX15—asthma	4.88e-06	4.54e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALOX5AP—asthma	4.88e-06	4.54e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—VEGFA—asthma	4.72e-06	4.39e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—STAT3—asthma	4.67e-06	4.35e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CHAT—asthma	4.66e-06	4.33e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—TGFB1—asthma	4.33e-06	4.03e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—EGFR—asthma	4.25e-06	3.95e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALOX5—asthma	4.15e-06	3.86e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CARM1—asthma	3.96e-06	3.68e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—DCN—asthma	3.9e-06	3.63e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALDH2—asthma	3.79e-06	3.53e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTT1—asthma	3.61e-06	3.36e-05	CbGpPWpGaD
Tasosartan—AGTR1—Signaling Pathways—IL6—asthma	3.27e-06	3.04e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NQO1—asthma	3e-06	2.79e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ADCY2—asthma	2.94e-06	2.73e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTP1—asthma	2.5e-06	2.33e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—HMOX1—asthma	2.47e-06	2.3e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ITPR1—asthma	2.46e-06	2.29e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—CAT—asthma	2.43e-06	2.27e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PLA2G4A—asthma	2.3e-06	2.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—GSTM1—asthma	2.3e-06	2.14e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PPP2CA—asthma	2.12e-06	1.97e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—POMC—asthma	1.63e-06	1.51e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—ALB—asthma	1.48e-06	1.38e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—NOS3—asthma	1.42e-06	1.32e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTGS2—asthma	1.3e-06	1.21e-05	CbGpPWpGaD
Tasosartan—CYP3A4—Metabolism—PTEN—asthma	1.13e-06	1.05e-05	CbGpPWpGaD
